About Human Thyroid-Stimulating Hormone Receptor (TSHR) Stable Cell Line

Thyroid-Stimulating Hormone Receptor (TSHR), also known as thyrotropin receptor, is a Class A G protein-coupled receptor (GPCR) that serves as the primary receptor for thyroid-stimulating hormone (TSH), a glycoprotein hormone secreted by the anterior pituitary gland. TSHR is predominantly expressed on thyroid follicular cells, where it plays a central role in regulating thyroid gland growth, thyroid hormone synthesis, and endocrine homeostasis. Upon activation by TSH, TSHR primarily couples to Gs proteins, stimulating adenylate cyclase activity and increasing intracellular cAMP levels. In certain cellular contexts, TSHR can also activate Gq-mediated signaling pathways, leading to phospholipase C activation and intracellular calcium mobilization.

TSHR is a master regulator of thyroid function and controls the production and secretion of the thyroid hormones thyroxine (T4) and triiodothyronine (T3), which are essential for metabolism, growth, development, and energy homeostasis. Dysregulation of TSHR signaling is associated with several thyroid disorders, including Graves' disease, hyperthyroidism, hypothyroidism, thyroid adenomas, and thyroid cancer. In Graves' disease, stimulating autoantibodies activate TSHR independently of TSH, resulting in excessive thyroid hormone production. Consequently, TSHR has become an important therapeutic target in endocrinology, autoimmune disease research, and thyroid drug development.

eEnzyme's Human TSHR Stable Cell Line provides a reliable and reproducible cellular platform for investigating TSHR-mediated signaling pathways and evaluating receptor-targeted therapeutics. The cell line enables quantitative assessment of TSH analogs, stimulating and blocking antibodies, agonists, antagonists, and novel receptor modulators through cAMP assays, reporter gene assays, and other GPCR functional screening platforms. Researchers can utilize this stable cell line for receptor characterization, potency determination, autoantibody testing, lead optimization, and high-throughput screening applications supporting endocrine and autoimmune disease research.

Applications of the TSHR Stable Cell Line

• TSH receptor pharmacology studies
• Thyroid hormone regulation research
• Graves' disease and autoimmune thyroid disease studies
• Stimulating and blocking antibody characterization
• Agonist and antagonist screening
• Endocrinology and thyroid biology research
• cAMP and GPCR functional assays
• High-throughput screening applications

Biological Significance of TSHR

TSHR is the central regulator of thyroid gland physiology and endocrine function. Activation of TSHR stimulates thyroid hormone synthesis, iodine uptake, thyroglobulin production, and thyroid cell growth through cAMP-dependent signaling pathways. The receptor plays a critical role in maintaining metabolic rate, thermogenesis, cardiovascular function, growth, and neurological development through regulation of circulating T3 and T4 levels. Autoimmune activation of TSHR is the primary cause of Graves' disease, making the receptor a clinically important biomarker and therapeutic target. In addition, TSHR signaling contributes to thyroid gland development and has been implicated in thyroid tumor biology. Because of its fundamental role in endocrine regulation and thyroid disease pathogenesis, TSHR remains one of the most important GPCR targets in endocrinology, autoimmune disease research, and therapeutic development. The TSHR Stable Cell Line provides a valuable tool for studying thyroid receptor biology and advancing the development of next-generation therapeutics targeting thyroid disorders.